Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: Effect of antioxidant treatment

D. Ferro, M. Saliola, P. L. Meroni, G. Valesini, C. Caroselli, D. Praticó, G. A. Fitzgerald, Y. Shoenfeld, F. Violi

Research output: Contribution to journalArticlepeer-review

Abstract

In a first study, we performed a cross-sectional analysis of urinary excretion of isoprostanes, IPF 2α-III and VI, and monocyte tissue factor (TF) antigen and activity between 11 antiphospholipid (APL) antibody-positive patients and 13 APL negative subjects. In a second study, 11 APL positive patients were randomly supplemented either with (n=6) or without (n=5) antioxidants (vitamin E at 900 IU day -1, vitamin C at 2000 mg day -1) for 6 weeks. In a third study, TF and superoxide anion were measured in human monocytes incubated with anti β 2 glycoprotein 1 (β 2GP 1) or control IgG, either with or without vitamin E. APL-positive patients had higher values of isoprostanes (P2α-III (rho 0.79; P2α-VI (rho=0.87; P2GP 1 antibodies dose-dependently enhanced the monocyte production of the superoxide anion and TF, which were significantly inhibited by vitamin E. This study demonstrates that in APL-positive patients, oxidative stress contributes to activate the clotting system via over-expression of monocyte TF. We suggest that anti-β 2GP 1 antibodies could play a pivotal role by enhancing the monocyte production of oxygen free radicals.

Original languageEnglish
Pages (from-to)523-531
Number of pages9
JournalJournal of Thrombosis and Haemostasis
Volume1
Issue number3
DOIs
Publication statusPublished - Mar 2003

Keywords

  • Antiphospholipid antibodies
  • Oxidative stress
  • Tissue factor

ASJC Scopus subject areas

  • Hematology
  • Medicine(all)

Fingerprint

Dive into the research topics of 'Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: Effect of antioxidant treatment'. Together they form a unique fingerprint.

Cite this